The Company’s Receipt of Approval for the Multidisciplinary “Reactivation” Program Designed by its Wholly Owned Subsidiary is a Major Milestone That is Expected to Benefit Veterans and First Responders for the Foreseeable Future

VANCOUVER, British Columbia, March 03, 2022 (GLOBE NEWSWIRE) — Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: MY0), an evidence-based healthcare company focused on innovative clinical solutions, artificial intelligence-powered digital therapeutics and contract research, is pleased to announce that its wholly owned subsidiary, IRP Health Ltd. (“IRP” or the “Subsidiary”) has recently had its innovative Reactivation therapy program (“Reactivation” or the “Therapy
Program”) formally approved by Veterans Affairs Canada (“VAC”) as an interdisciplinary clinic outpatient program at three locations. IRP currently has four clinic locations across Canada and is among the first operators to meet VAC’s new criteria that is aimed at providing high-quality programs for veterans. The Company expects IRP’s location in Ottawa, Ontario to also be approved to offer the Therapy Program by VAC imminently.

Reactivation is a 12-week, physician-supervised, interdisciplinary pain management program that assists veterans with chronic musculoskeletal injuries and pain. The Therapy Program aims to help veterans return to behaviours that are consistent with being well, rather than behaviours that are consistent with suffering. The goals of Reactivation are to decrease distressing symptoms, increase engagement in the community and increase the ability to complete daily tasks. The Therapy Program also strives to reduce patient disability in both the short and long term, while giving veterans better control and understanding of their pain and health challenges. Reactivation combines psychiatry, psychology, occupational therapy, physiotherapy, kinesiology and dietetics to provide an interdisciplinary approach and a cutting-edge treatment.

Founded in 2016, IRP began as a rehabilitation and performance centre offering exercise therapy and rehabilitation programs in Victoria, British Columbia. IRP builds safe and supportive environments while demonstrating modern, evidence-based physical rehabilitation programs designed specifically for the needs of veterans and first responders. Building on the success of over 15,000 treatments in the flagship Victoria location. IRP is adding new locations and programs to improve access to much needed treatments.

VAC is a government organization for current and former members of the Canadian Armed Forces, Royal Canadian Mounted Police or their family members. It provides services and benefits intended to improve the well-being of veterans and their kin with the estimated total number of veterans in Canada being 617, 800.1 Of these veterans, it is estimated that more than 24% of them have a mental illness, such as PTSD, and 95% of those veterans have been diagnosed with a chronic physical health condition.2 The approval of the Therapy Program has the potential to make a difference in the lives of many veterans who are coping with mental and physical illnesses.

“VAC’s approval of the Reactivation program is a significant milestone for Wellbeing and for the physical and mental health of veterans. This brings us one step closer to achieving our goal of a Canadian wide network of purpose-built programs for veterans and first responders who desperately need access to care,” said Adam Deffett, Interim CEO of Wellbeing. “I am very proud of IRP’s achievements and we fully committed to further expanding their work. These are the moments that fuel Wellbeing’s growth and the achievement of its goals to positively impact the mental health realm,” added Mr. Deffett.

Veterans and first responders looking for more information on Reactivation and IRP locations can visit www.irphealth.ca or call +1 (778) 535-5312.

‍

ABOUT WELLBEING DIGITAL SCIENCES

Wellbeing Digital Sciences Inc. (formerly KetamineOne Capital Limited) is an evidence-based healthcare company focused on innovative clinical solutions, artificial intelligence-powered digital therapeutics and contract research. Its mission is supported by a network of North American clinics that provide ketamine-assisted therapies and other types of treatment to patients as well as through a contract research organization that offer clinical trials services to clients pursuing drug development. In essence, the company exists to make breakthrough treatments more accessible and to offer patients transformational experiences.

On behalf of:

WELLBEING DIGITAL SCIENCES INC.

“Adam Deffett“
Adam Deffett, Interim CEO

For further information, please contact:

Nick Kuzyk, Investor Relations
Tel: 1-844-746-6351
Email: [email protected]

Web: www.wellbeingdigital.co
Twitter: @Wellbeing_IR

Notice Regarding Forward-Looking Information:

This news release contains forward-looking statements including but not limited to statements regarding the Company’s business, assets or investments, as well other statements that are not historical facts. Readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties, both general and specific, that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which may cause actual performance and results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. These assumptions, risks and uncertainties include, among other things, the state of the economy in general and capital markets in particular, investor interest in the business and prospects of the Company.

The forward-looking statements contained in this news release are made as of the date of this news release. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities law. Additionally, the Company undertakes no obligation to comment on the expectations of, or statements made, by third parties in respect of the matters discussed above.

Endnotes:

1. “Demographics”, Government of Canada, March 31 2021, https://www.veterans.gc.ca/eng/about-vac/news-media/facts-figures/1-0
2. “Understanding mental health”, Government of Canada, March 31 2021, https://www.veterans.gc.ca/eng/health-support/mental-health-and-wellness/understanding-mental-health

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

By Rebecca Victoria Olmos

In April, co-chairs of the Congressional Cannabis Caucus, Representatives Barbara Lee (D-CA) and Dave Joyce (R-OH), joined Senator Brian Schatz (D-HI) to introduce the Veterans Medical Marijuana Safe Harbor Act of 2021. This bill would allow Veterans Affairs (VA) doctors to discuss and recommend cannabis as treatment in states where weed is legal and research its effects.

Because of weed’s federally illegal status, the VA cannot recommend it as a possible treatment option. There are also limitations on the ability to conduct medical research on cannabis and its effects on different mental health conditions, physical ailments, and how it interacts with other medications. These are crucial factors to consider when treating a human with layers of medical conditions and trauma.

“It has been scientifically proven that medical marijuana has a considerable impact in treating conditions common with veterans when they return from service, like chronic pain and PTSD,” Lee said in a press release.

Veterans who return safely home often deal with more than one health issue due to their service. According to the National Academy of Sciences, these include anxiety, depression, post-traumatic stress disorder, chronic pain, and an array of others.

Doctors with the VA currently treat these ailments with prescription drugs. While these drugs can be helpful, they also can have adverse side effects like headaches, gastrointestinal conditions, and seizures.

Veterans often self-prescribe cannabis as an alternative medicine because it has less drastic side effects. A 2019 nationwide study done by the Iraq and Afghanistan Veterans of America found that 75% of veterans would consider using cannabis as treatment if it was made available to them.

The Veterans Medical Marijuana Safe Harbor Act of 2021 would provide five-year safe harbor protection for veterans and their doctors. This legislation is one of a few bills introduced this year to lift federal restrictions on cannabis research and recommendations for veterans.